Abiopharma

🔍 Cullinan Brian (Executive)

Company: Corvex, Inc. (MOVE)

Report Date: 2026-06-30

Detailed Transactions and Holdings:

• Acquired 48,209 shares of Common Stock at $0.92 per share (Direct)
  Date: 2026-06-30 | Code: M | equity_swap_involved: false | shares_owned_after: 61,276.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 48,209 shares of Stock Options (Right to Buy) at $0.92 per share (Derivative)
  Date: 2026-06-30 | Code: M | Expires: 2026-06-30 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend.
• F2: This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend.